Run
202080

Run 202080

Task 4647 (Supervised Classification) tumors_C Uploaded 27-02-2015 by Joaquin Vanschoren
0 likes downloaded by 0 people 0 issues 0 downvotes , 0 total downloads
Issue #Downvotes for this reason By


Flow

weka.IBk(4)D. Aha, D. Kibler (1991). Instance-based learning algorithms. Machine Learning. 6:37-66.
weka.IBk(4)_K3
weka.IBk(4)_W0
weka.IBk(4)_Atrue

Result files

xml
Description

XML file describing the run, including user-defined evaluation measures.

model
Model readable

A human-readable description of the model that was built.

model
Model serialized

A serialized description of the model that can be read by the tool that generated it.

arff
Predictions

ARFF file with instance-level predictions generated by the model.

22 Evaluation measures

0.5558
Per class
Cross-validation details (10 times 10-fold Crossvalidation)
0.5909
Per class
Cross-validation details (10 times 10-fold Crossvalidation)
0.1198
Cross-validation details (10 times 10-fold Crossvalidation)
-15.0988
Cross-validation details (10 times 10-fold Crossvalidation)
0.4577
Cross-validation details (10 times 10-fold Crossvalidation)
0.4565
Cross-validation details (10 times 10-fold Crossvalidation)
600
Per class
Cross-validation details (10 times 10-fold Crossvalidation)
[Oracle Corporation, 1.7.0_75, amd64, Linux, 3.16.0-29-generic]
0.6003
Per class
Cross-validation details (10 times 10-fold Crossvalidation)
0.585
Cross-validation details (10 times 10-fold Crossvalidation)
0.9383
Cross-validation details (10 times 10-fold Crossvalidation)
0.585
Per class
Cross-validation details (10 times 10-fold Crossvalidation)
1.0028
Cross-validation details (10 times 10-fold Crossvalidation)
0.477
Cross-validation details (10 times 10-fold Crossvalidation)
0.5322
Cross-validation details (10 times 10-fold Crossvalidation)
1.1158
Cross-validation details (10 times 10-fold Crossvalidation)
1372.2145
430
Cross-validation details (10 times 10-fold Crossvalidation)
430
Cross-validation details (10 times 10-fold Crossvalidation)
Cross-validation details (10 times 10-fold Crossvalidation)